RE:RE:RE:RE:Beam Therapeutics Phase 1 CAR-T study placed on hold by FDAYou Canadfan wrote:
One of a few things can & eventually will happen.
1. the Pela technology will prove out & market value will adjust upward.
2. the Pela technology will not prove out & justify the existing value.
Simple logic
No -- not simple logic -- flawed logic for reasons that I already provided in the 2 preclinical examples involving Trillium and Beam Therapeutics whereby in Trillium's example the company does not have a proven technolgy and in the other, Beam has both an unproven technology PLUS a stalled Phase 1 study ... YET one company was aquired for US$2.3 Billion and the other has a market cap of $USD4.5 Billion. Neither have a proven technology but are worth $Billions each and neither had anything to do with the any justification of existing value as you stated.
So your logic does not hold any water. In fact your logic is so simple that it makes little the real world that I have cited rejects it in its totality. You simply assumed that if something works then its a good thing but as in the case of Beam Therapeutics, if something doesn't work the market still thinks its a good thing and continues to keep the stock trading high. That is because in the world of immuno-oncology and medicine, if is unproven or fails in one area it doesn't mean that it doesn't have value in the same area as well as some other another. So you see ... your "black versus white" logic is flawed except for someone who is looking to swing-trade, or betting on black versus red, or the throw of the dice as gamblers have, which is what you admitted you have been doing with ONCY - thus making much what you post suspicious and your logic simply flawed.